AAAAAA

   
Results: 1-21 |
Results: 21
Liver cirrhosis - Pathogenesis and diagnosis
Authors: Rabe, C Heller, J Sauerbruch, T Caselmann, WH
Citation: C. Rabe et al., Liver cirrhosis - Pathogenesis and diagnosis, DEUT MED WO, 126(36), 2001, pp. 975-975
Liver cirrhosis - Case report
Authors: Rabe, C Heler, J Sauerbruch, T Caselmann, WH
Citation: C. Rabe et al., Liver cirrhosis - Case report, DEUT MED WO, 126(36), 2001, pp. 975-977
Liver cirrhosis - Complications and treatment
Authors: Schepke, M Reichel, C Ziske, C Spengler, U Caselmann, WH Sauerbruch, T
Citation: M. Schepke et al., Liver cirrhosis - Complications and treatment, DEUT MED WO, 126(36), 2001, pp. 978-981
Design and properties of hepatitis C virus antisense oligonucleotides for liver specific drug targeting
Authors: Lehmann, TJ Serwe, M Caselmann, WH Engels, JW
Citation: Tj. Lehmann et al., Design and properties of hepatitis C virus antisense oligonucleotides for liver specific drug targeting, NUCLEOS NUC, 20(4-7), 2001, pp. 1343-1346
Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension
Authors: Schepke, M Werner, E Biecker, E Schiedermaier, P Heller, J Neef, M Stoffel-Wagner, B Hofer, U Caselmann, WH Sauerbruch, T
Citation: M. Schepke et al., Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension, GASTROENTY, 121(2), 2001, pp. 389-395
Frequent genomic imbalances suggest commonly altered tumour genes in humanhepatocarcinogenesis
Authors: Niketeghad, F Decker, HJ Caselmann, WH Lund, P Geissler, F Dienes, HP Schirmacher, P
Citation: F. Niketeghad et al., Frequent genomic imbalances suggest commonly altered tumour genes in humanhepatocarcinogenesis, BR J CANC, 85(5), 2001, pp. 697-704
Carcinogenesis of primary liver malignancies
Authors: Durr, R Caselmann, WH
Citation: R. Durr et Wh. Caselmann, Carcinogenesis of primary liver malignancies, LANG ARCH S, 385(3), 2000, pp. 154-161
Intraarterial HCC therapy with I-131-Lipiodol
Authors: Risse, JH Grunwald, E Kersjes, W Strunk, H Caselmann, WH Palmedo, H Bender, H Biersack, HJ
Citation: Jh. Risse et al., Intraarterial HCC therapy with I-131-Lipiodol, CANC BIO R, 15(1), 2000, pp. 65-70
Interaction of hepatitis B virus with cellular processes in liver carcinogenesis
Authors: Rabe, C Caselmann, WH
Citation: C. Rabe et Wh. Caselmann, Interaction of hepatitis B virus with cellular processes in liver carcinogenesis, CR R CL LAB, 37(5), 2000, pp. 407-429
Efficient gene transfer into lymphoma cells using adenoviral vectors combined with lipofection
Authors: Buttgereit, P Weineck, S Ropke, G Marten, A Brand, K Heinicke, T Caselmann, WH Huhn, D Schmidt-Wolf, IGH
Citation: P. Buttgereit et al., Efficient gene transfer into lymphoma cells using adenoviral vectors combined with lipofection, CANC GENE T, 7(8), 2000, pp. 1145-1155
The potential of gene therapy in the treatment of hepatocellular carcinoma
Authors: Qian, C Drozdzik, M Caselmann, WH Prieto, J
Citation: C. Qian et al., The potential of gene therapy in the treatment of hepatocellular carcinoma, J HEPATOL, 32(2), 2000, pp. 344-351
Rapid and reproducible quantification of hepatitis C virus cDNA by fluorescence correlation spectroscopy
Authors: Weiner, OH Alt, M Durr, R Noegel, AA Caselmann, WH
Citation: Oh. Weiner et al., Rapid and reproducible quantification of hepatitis C virus cDNA by fluorescence correlation spectroscopy, DIGESTION, 61(2), 2000, pp. 84-89
Management of poisoning with Amanita phalloides
Authors: Rabe, C Scheurlen, C Caselmann, WH
Citation: C. Rabe et al., Management of poisoning with Amanita phalloides, DEUT MED WO, 124(37), 1999, pp. 1073-1076
Hepatic disease
Authors: Sauerbruch, T Caselmann, WH Spengler, U
Citation: T. Sauerbruch et al., Hepatic disease, EUR J GASTR, 11(1), 1999, pp. 41-46
Guidelines of the DGVS on diagnostics and therapy of hepatocellular carcinoma
Authors: Caselmann, WH Blum, HE Fleig, WE Huppert, PE Ramadori, G Schirmacher, P Sauerbruch, T
Citation: Wh. Caselmann et al., Guidelines of the DGVS on diagnostics and therapy of hepatocellular carcinoma, Z GASTROENT, 37(5), 1999, pp. 353-365
Differential antigen-processing pathways of the hepatitis B virus e and core proteins
Authors: Diepolder, HM Ries, G Jung, MC Schlicht, HJ Gerlach, JT Gruner, N Caselmann, WH Pape, GR
Citation: Hm. Diepolder et al., Differential antigen-processing pathways of the hepatitis B virus e and core proteins, GASTROENTY, 116(3), 1999, pp. 650-657
Comparative inhibitory potential of differently modified antisense oligodeoxynucleotides on hepatitis C virus translation
Authors: Alt, M Eisenhardt, S Serwe, M Renz, R Engels, JW Caselmann, WH
Citation: M. Alt et al., Comparative inhibitory potential of differently modified antisense oligodeoxynucleotides on hepatitis C virus translation, EUR J CL IN, 29(10), 1999, pp. 868-876
Combination therapy of chronic hepatitis C: an important step but not the final goal!
Authors: Wedemeyer, H Caselmann, WH Manns, MP
Citation: H. Wedemeyer et al., Combination therapy of chronic hepatitis C: an important step but not the final goal!, J HEPATOL, 29(6), 1998, pp. 1010-1014
Primary manifestation of hepatocellular carcinoma as osteolytic hand metastasis
Authors: Delsmann, BM Lienemann, A Nerlich, A Hoffmann, E Caselmann, WH Refior, HJ
Citation: Bm. Delsmann et al., Primary manifestation of hepatocellular carcinoma as osteolytic hand metastasis, Z ORTHOP GR, 136(6), 1998, pp. 571-573
Mutational analysis of two unstructured domains of the 5 ' untranslated region of HCV RNA
Authors: Varaklioti, A Georgopoulou, U Kakkanas, A Psaridi, L Serwe, M Caselmann, WH Mavromara, P
Citation: A. Varaklioti et al., Mutational analysis of two unstructured domains of the 5 ' untranslated region of HCV RNA, BIOC BIOP R, 253(3), 1998, pp. 678-685
Transactivators of HBV, signal transduction and tumorigenesis
Authors: Caselmann, WH Koshy, R
Citation: Wh. Caselmann et R. Koshy, Transactivators of HBV, signal transduction and tumorigenesis, HEPATITIS B VIRUS, 1998, pp. 161-181
Risultati: 1-21 |